Premium Rx NationalPublic shortage context is available across 3 visible exact NDC pages for this generic drug family.
This family page is organized from FDA/openFDA shortage records and other publicly available source material, then indexed by generic drug name, manufacturer, NDC, and package details for faster browsing.
Current and historical shortage references are available across related Erythromycin Lactobionate presentations from multiple manufacturers.
Use the exact NDC page when your team needs package-level product details, public shortage references, and the strongest route into RFQ and sourcing workflows. These links open directly to the Drug Shortage Information section for each product page.
| Drug Name | NDC 11 | Manufacturer | Shortage Context |
|---|---|---|---|
| Erythromycin Lactobionate 500 mg / 100mL Injection 100 mL (Erythrocin Lactobionate) NDC 00409-6476-44 | 10 Vial, Patent Delivery System | Hospira, Inc. | 00409-6476-44 | Hospira, Inc. | Current shortage context |
| Erythromycin Lactobionate 500 mg / 10mL Injection 10 mL NDC 14789-0116-05 | 5 Vial, Glass | Nexus Pharmaceuticals LLC | 14789-0116-05 | Nexus Pharmaceuticals LLC | Current shortage context |
| Erythromycin Lactobionate 500 mg / 10mL Injection 10 mL (Erythrocin Lactobionate) NDC 00409-6482-01 | 10 Vial | Hospira, Inc. | 00409-6482-01 | Hospira, Inc. | Historical shortage context |
These exact presentation links are useful for brand-name, size, and NDC-specific searches related to this shortage family.
Unless explicitly stated in writing, no direct affiliation, sponsorship, or endorsement by individual product manufacturers with Premium Rx National, LLC should be implied. All brand names, trade names, and trademarks are the property of their respective owners and are presented solely for accurate product identification and informational reference.